Teladoc Health(纳斯达克交易代码:TDOC)股价在2025年2月26日星期三的夜盘大跌16.01%,引发投资者关注。
根据公司发布的2024年第四季度业绩报告,该季度Teladoc Health销售额为6.405亿美元,同比下滑3.03%。虽然销售额数字高于分析师预期,但下滑趋势令投资者担忧公司增长前景。
此外,季度亏损也大幅超出市场预期。Teladoc Health2024年第四季度每股亏损0.28美元,较上年同期加大64.71%,远高于分析师预期的0.23美元亏损。亏损扩大进一步加剧了投资者对公司盈利能力的忧虑。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.